Newmark：2025年第三季度美国生命科学市场状况及趋势报告（英文版）

The U.S. life science market showed early stabilization in the third quarter as leasing and tenant demand modestly improved after several quarters of slowdown. Vacancy rates climbed only slightly, signaling that the correction phase may be nearing its end. While national fundamentals remain challenged, activity in top markets such as Boston, San Diego and the Bay Area picked up, supported by a rebound in venture funding and the continued expansion of biomanufacturing investment. Funding and i